Latanoprost Stada (Latanoprost)

Latanoprost binds to FP receptors in the eye’s ciliary muscle, triggering remodeling of the extracellular matrix. This increases uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanoprost Stada is determined by the prescribing clinician. Typically, a single drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk, and a healthcare professional should be consulted.

To order Latanoprost Stada, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often achieve greater pressure reduction with a favorable dosing schedule, though individual response may vary.

Latanoprost Stada should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and do not freeze the solution. Discard any product that appears discolored or contaminated.

The medication is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. Patients should wash their hands before use, avoid touching the tip of the bottle to any surface, and wait a few minutes before applying other eye drops.

Serious risks, though rare, include severe allergic reactions such as angio‑edema, uveitis, corneal edema, and persistent eye pain that could lead to vision loss. Any sudden change in vision, severe eye discomfort, or signs of infection should prompt immediate medical attention.

Latanoprost Stada should be avoided in patients with known hypersensitivity to latanoprost or any component of the formulation, active ocular infections, or inflammation such as uveitis. Caution is also advised for individuals using other prostaglandin analog eye drops.